Technology Week Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.

Press releases published on April 20, 2026

Apr. 20, 2026

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region

Indeterminate GlobeNewswire

Apr. 20, 2026

AlphaTON Capital Rebrands as Alpha Compute Corp. to Reflect Its Growing AI Compute Business

Indeterminate GlobeNewswire

Apr. 20, 2026

Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial

Indeterminate GlobeNewswire

Apr. 20, 2026

Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons

Indeterminate GlobeNewswire

Apr. 20, 2026

Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit

Indeterminate GlobeNewswire

Apr. 20, 2026

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

Indeterminate GlobeNewswire

Apr. 20, 2026

Aikido Security Launches Endpoint Protection for Developer Devices as Software Supply Chain Attacks Hit Unprecedented Scale

Indeterminate GlobeNewswire

Apr. 20, 2026

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors

Indeterminate GlobeNewswire

Apr. 20, 2026

SPARC AI Signs Second Ukrainian Drone Manufacturer, Expanding Distribution Footprint for GPS-Denied Software Platform

Indeterminate GlobeNewswire

Apr. 20, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

Indeterminate GlobeNewswire

Apr. 20, 2026

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

TransAlta Appoints Mike Politeski as Chief Financial Officer and Grant Arnold as Chief Commercial Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

Bodor Laser Ranked No. 1 in Global Sales Volume for Seven Consecutive Years, Demonstrating Brand Strength Through Sustained Leadership

Indeterminate GlobeNewswire

Apr. 20, 2026

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

Indeterminate GlobeNewswire

Apr. 20, 2026

Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference

Indeterminate GlobeNewswire

Apr. 20, 2026

Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics

Indeterminate GlobeNewswire

Apr. 20, 2026

BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026

Indeterminate GlobeNewswire